CIK 0001620463
- Non-accelerated filer
- Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 453368487
- Phone
- +1 425-620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- Open-market buys, last 90 days
- $9,919,161,281
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-10 | MILESON GLENNA Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −6,305 | 6,305 | ||
| 2021-06-08 | CHURCH KEVIN Vice President of Discovery | Exercise or conversion | +3,152 | $1.04 | $3K | 44,318 |
| 2021-06-08 | CHURCH KEVIN Vice President of Discovery | Exercise or conversion · Stock Option (Right to Buy) | −3,152 | 0 | ||
| 2021-06-08 | CHURCH KEVIN Vice President of Discovery | Exercise or conversion | +3,152 | $1.04 | $3K | 44,133 |
| 2021-06-08 | CHURCH KEVIN Vice President of Discovery | Exercise or conversion · Stock Option (Right to Buy) | −3,152 | 0 | ||
| 2021-05-28 | FLUKE JOHN M JR Director | Grant or award · Stock Option (Right to Buy) | +13,871 | 13,871 | ||
| 2021-05-28 | Yamada Tadataka Director | Grant or award · Stock Option (Right to Buy) | +13,871 | 13,871 | ||
| 2021-05-28 | JOHNSON JAMES A Director | Grant or award · Stock Option (Right to Buy) | +13,871 | 13,871 | ||
| 2021-05-28 | EDELMAN JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +13,871 | 13,871 | ||
| 2021-05-28 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Stock Option (Right to Buy) | +13,871 | 13,871 | ||
| 2021-05-18 | Litton Mark James Chief Operating Officer | Grant or award | +867 | $14.45 | $13K | 64,433 |
| 2021-05-18 | MOEBIUS HANS Chief Medical Officer | Grant or award | +2,055 | $14.45 | $30K | 2,055 |
| 2021-05-18 | MILESON GLENNA Chief Financial Officer | Grant or award | +1,554 | $14.45 | $22K | 83,519 |
| 2021-05-18 | CHURCH KEVIN Vice President of Discovery | Grant or award | +185 | $14.45 | $3K | 41,166 |
| 2021-03-04 | Kosacz Barbara Director | Grant or award · Stock Option (Right to Buy) | +27,742 | 27,742 | ||
| 2021-02-18 | MOEBIUS HANS Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +72,000 | 72,000 | ||
| 2021-02-18 | MILESON GLENNA Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +73,500 | 73,500 | ||
| 2021-02-18 | Litton Mark James Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2021-02-18 | KAWAS LEEN President & CEO | Grant or award · Stock Option (Right to Buy) | +231,000 | 231,000 | ||
| 2021-02-18 | CHURCH KEVIN Vice President of Discovery | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 16 of 18 · 349 trades